Cephalexin (Cefalexin)

Subscribe to Selected New Research on Cephalexin

478 relevant articles (60 outcomes, 66 trials/studies) found for this Drug

Description: A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.

Also Known As:

Cefalexin; Cephalexin Dihydride; Cephalexin Hemihydrate; Cephalexin Hydrochloride; Cephalexin Monohydrate; Cephalexin Monohydrochloride; Cephalexin Monohydrochloride, Monohydrate; Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer; Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer; Cephalexin, (6R-(6alpha,7beta))-Isomer; Cephalexin, Monosodium Salt; Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer; Ceporexine; Palitrex; Dihydride, Cephalexin; Hemihydrate, Cephalexin; Hydrochloride, Cephalexin; Monohydrate Cephalexin Monohydrochloride; Monohydrate, Cephalexin; Monohydrochloride, Cephalexin; Monohydrochloride, Monohydrate Cephalexin; Monosodium Salt Cephalexin; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-

Relationship Network

Drug Context: Research Results

Experts

1.	Parish, L C: 2 articles (01/2002 - 10/2000)
2.	Persico, P: 1 article (08/2008)
3.	Noli, C: 1 article (08/2008)
4.	Colombo, S: 1 article (08/2008)
5.	Toma, S: 1 article (08/2008)
6.	Cornegliani, L: 1 article (08/2008)
7.	Galzerano, M: 1 article (08/2008)
8.	Gianino, M M: 1 article (08/2008)
9.	Wing, Deborah A: 1 article (05/2008)
10.	Chung, Judith H: 1 article (05/2008)

Related Diseases

1.	Infection 08/01/1991 - "However, by recommending a 1-day strategy of oral cephalexin only to those dental patients at high risk for late prosthetic joint infections rather than a 3-day regimen to all patients, the cost effectiveness improved from $1.1 million/QALY to $446,100/QALY while maintaining a low risk of death (0.38 deaths per 10(6) dental visits)." 03/01/1982 - "Cephalexin appeared to be equally effective in treatment of both ACB-positive and ACB-negative infections. " 01/01/2005 - "Fixation problems included two pin-track infections cleared with oral cephalexin and one broken half-pin. " 03/01/1986 - "Those patients with infections caused by cephalexin-susceptible organisms were cured at a rate similar to that for patients with infections caused by cephalexin-resistant organisms (68 versus 50%; P = 0.62). " 04/01/1981 - "The efficacy of cephalexin administered twice a day was compared to the same drug administered four times a day for the treatment of skin and skin structure infections due to staphylococcus and/or streptococcus. " Order ALL the reference details at left...
2.	Urinary Tract Infections (Urinary Tract Infection) 11/01/1989 - "Postcoital oral cephalexin prophylaxis is highly effective in the prevention of recurrent urinary tract infection in the nonpregnant as well as pregnant premenopausal women because of easy compliance, the high urine concentration achieved and the minimal induction of resistance to cephalexin in the introital gram-negative bacterial flora. " 03/01/1986 - "The efficacy of single-dose therapy with 3 g of cephalexin was evaluated in 129 women with symptoms of acute uncomplicated lower urinary tract infections. " 01/01/1983 - "Cephalexin is essentially nontoxic at recommended doses, and its clinical efficacy in urinary tract infections has been repeatedly documented in numerous studies since 1971." 03/20/1973 - "[Clinical and bacteriological studies on the course of 31 cases of most severe chronic urinary tract infections during mainly discordant cephalexin medication]" 01/01/1999 - "Synergistic bactericidal effect of cephalexin and normal cord serum (NCS) against Escherichia coli K1 strains isolated from children with urinary tract infections (UTI)." Order ALL the reference details at left...
3.	Pyoderma 08/01/2008 - "CLINICAL SIGNIFICANCE: Once-daily cephalexin is as effective as twice-daily cephalexin in the treatment of canine superficial pyoderma." 08/01/2008 - "OBJECTIVES: The aims of this study were to evaluate the efficacy and tolerability of oral cephalexin given at 30 mg/kg once daily in dogs with superficial pyoderma and to compare them with those of oral cephalexin given at 15 mg/kg twice daily. " 08/01/2008 - "Efficacy and tolerability of once-daily cephalexin in canine superficial pyoderma: an open controlled study." 08/01/2008 - "METHODS: Twenty dogs with superficial pyoderma were treated with cephalexin at 30 to 60 mg/kg orally once daily (group A) and compared with 20 dogs treated at a dose of 15 to 30 mg/kg orally twice daily (group B). " 02/01/1971 - "[Treatment of pyoderma with cephalexin]" Order ALL the reference details at left...
4.	Soft Tissue Infections 01/01/1983 - "The role of cephalexin in the treatment of skin and soft-tissue infections." 01/01/1981 - "Considering the lower respiratory and soft tissue infections together, 1 g cephalexin twice daily produced a better clinical response after 48-hours' treatment, suggesting a more rapid response with the higher dosage, but this trend did not reach statistical significance. " 06/17/1972 - "Cephalexin therapy of soft-tissue infection." 09/01/1970 - "[Cephalexin monohydrate in the treatment of bone and soft tissue infections]" 03/16/1970 - "Treatment of soft-tissue infection with cephalexin. " Order ALL the reference details at left...
5.	Abscess 11/01/2007 - "We conducted a randomized, double-blind trial of 166 outpatient subjects comparing placebo to cephalexin at 500 mg orally four times for 7 days after incision and drainage of skin and soft tissue abscesses. " 11/01/2007 - "Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection." 07/01/2009 - "METHODS: This study included 90 patients with acute odontogenic abscess who received surgical treatment (extraction of a teeth and/or abscess incision) and were divided into three groups: two surgical-antibiotic groups (amoxicillin, cefalexin) and the surgical group. " 07/01/2009 - "The aim of this study was to investigate the clinical efficiency of amoxicillin and cefalexin in the empirical treatment of acute odontogenic abscess and to assess the antimicrobial susceptibility of the isolated bacteria in early phases of its development. " 07/01/2009 - "Bacterial strains isolated in early stages of dentoalveolar abscess showed high sensitivity to amoxicillin and cefalexin." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Ampicillin (Omnipen)
2.	Cefadroxil (Duricef)
3.	Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)
4.	Trimethoprim (Proloprim)
5.	Cephalothin (Cefalotin)
6.	retapamulin
7.	Cefaclor (Ceclor)
8.	Amoxicillin (Wymox)
9.	Ciprofloxacin (Cipro)
10.	Mupirocin (Bactroban)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Antibiotic Prophylaxis
3.	Oral Administration
4.	Continuous Ambulatory Peritoneal Dialysis (CAPD)
5.	Injections

Best Treatments:
Research Summary Report
on Infection

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 14726 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>